The classification of p53 immunohistochemical staining results and patient outcome in ovarian cancer

por Lassus, H, Butzow, R
Publicado 2007

Secretion of soluble complement inhibitors factor H and factor H-like protein (FHL-1) by ovarian tumour cells

por Junnikkala, S, Hakulinen, J, Jarva, H, Manuelian, T, Bjørge, L, Bützow, R, Zipfel, P F, Meri, S
Publicado 2002

Genetic alterations and protein expression of KIT and PDGFRA in serous ovarian carcinoma

por Lassus, H, Sihto, H, Leminen, A, Nordling, S, Joensuu, H, Nupponen, N N, Butzow, R
Publicado 2004

Prognostic role of CIP2A expression in serous ovarian cancer

por Böckelman, C, Lassus, H, Hemmes, A, Leminen, A, Westermarck, J, Haglund, C, Bützow, R, Ristimäki, A
Publicado 2011

A missense mutation in the BRCA2 gene in three siblings with ovarian cancer.

por Roth, S., Kristo, P., Auranen, A., Shayehgi, M., Seal, S., Collins, N., Barfoot, R., Rahman, N., Klemi, P. J., Grénman, S., Sarantaus, L., Nevanlinna, H., Butzow, R., Ashworth, A., Stratton, M. R., Aaltonen, L. A.
Publicado 1998

Somatic MED12 mutations in uterine leiomyosarcoma and colorectal cancer

por Kämpjärvi, K, Mäkinen, N, Kilpivaara, O, Arola, J, Heinonen, H-R, Böhm, J, Abdel-Wahab, O, Lehtonen, H J, Pelttari, L M, Mehine, M, Schrewe, H, Nevanlinna, H, Levine, R L, Hokland, P, Böhling, T, Mecklin, J-P, Bützow, R, Aaltonen, L A, Vahteristo, P
Publicado 2012